View Clinical Trial (Medical Research Study)

Abatacept Versus Adalimumab Head-to-Head - NCT00929864-53217(Clinical Trial 350854)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Glendale
State:  
WI
Zip Code: 53217
Conditions: Rheumatoid Arthritis
Purpose: The purpose of this study is demonstrate that subcutaneous abatacept is non-inferior (no worse than) to subcutaneous adalimumab in the treatment of subjects with rheumatoid arthritis who are biologic naive
Study summary:
Criteria: Inclusion Criteria: - Moderate to severe RA according to ACR criteria - MTX failure - Naive to RA biologics - ≤5 years duration of disease - DAS28 CRP ≥ 3.2 - Willingness to self-inject SC drug Exclusion Criteria: - Previous or current medical conditions that are warnings against the use of TNF-blocking agents - History of active or chronic hepatitis - Cancer in the last 5 years - History of severe chronic or recurrent bacterial or viral infections - Risk of tuberculosis - Current symptoms of severe, progressive, or uncontrolled renal, hepatic, hematologic, GI, pulmonary, cardiac, neurologic, or cerebral disease
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: January 6, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.